View drug registration information details.
Items | Registration information |
ID | 527 |
No | 527 |
Brand Name | HERCEPTIN 440 MG |
Ingredients | TRASTUZUMAB 440 MG |
Dosage Form | POWDER FOR SOLUTION FOR INFUSION |
Primary Packaging | VIAL |
Storage | STORE 2-8 C |
Shelf Life | 4 YEARS |
Pack Size | 440 MG/VIAL, 1 VIAL OF ACTIVE INGREDIENT AND 1 VIAL OF SOLVENT |
Dispensing Category | Prescription only |
ATC Classification | XX |
Pharmaceutical Class | ANTINEOPLASTICS |
Indications | METASTATIC BREAST CANCER AS MONOTHERAPY OR IN COMBINATION WITH PACLITAXEL OR DOCETAXEL OR AROMATASE INHIBITOR;- EARLY BREAST CANCER FOLLOWING SURGERY, CHEMOTHERAPY AND RADIOTHERAPY; ADVANCED GASTRIC CANCER IN COMBINATION WITH CAPECITABINE OR INTRAVENOUS 5 FLUOROURACIL AND PLATINUM AGENT. |
Contraindications | HYPERSENSITIVITY |
Side Effects | FEVER AND CHILLS, ABDOMINAL PAIN, ASTHENIA, CHEST PAIN, HEADACHE, DIARRHEA, NAUSEA, VOMITING |
Unit Price | XXXX |
EDL |
No |
Description | WHITE CAKE, SLIGHTLY OPALESCENT SOLUTION, COLORLESS AFTER RECONSTITUTION. |
Note | |
License Owner | DKSH LAOS COMPANY LIMITED |
Manufacturer | GENENTECH, INC |
Country | SWITZERLAND |
Import Registration No | 55'065 01 |
Import Registration Date | 2014-02-07 |
Activity | CERTIFICATE RELEASED |
Applied Date | 2024-08-08 |
FDD Registration No | 06 I 4472/18 |
FDD Registration Date | 2024-09-25 |
Expiry Date | 2029-09-24 |
Back to drug list
|